SCANCELL LIMITED

Active Oxford

Research and experimental development on biotechnology

60 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
S

SCANCELL LIMITED

Research and experimental development on biotechnology

Founded 7 Aug 1996 Active Oxford, England 60 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 9 Oct 2025 Next due 31 Jan 2027 8 months remaining
Confirmation Submitted 28 Jul 2025 Next due 3 Aug 2026 2 months remaining
Net assets £5M £7M 2025 year on year
Total assets £8M £1M 2025 year on year
Total Liabilities £4M £9M 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Bellhouse Building Sanders Road Oxford Science Park Oxford OX4 4GD England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for SCANCELL LIMITED (03234881), an active life sciences and medical technology company based in Oxford, England. Incorporated 7 Aug 1996. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Balance Sheet & P&L (2014–2025)

Cash in Bank

£1.68M

Increased by £822.00k (+96%)

Net Assets

£4.67M

Increased by £7.33M (+275%)

Total Liabilities

£3.50M

Decreased by £8.80M (-72%)

Turnover

£4.71M

Employees

60

Decreased by 1 (-2%)

Debt Ratio

43%

Decreased by 85 (-66%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 1

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 2Oct 2020Unknown/Other
Investor 1Dec 2024Unknown/Other

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Scancell Holdings Plc
99.5%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Scancell Holdings Plc

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors,significant Influence Or Control

Group Structure

Group Structure

SCANCELL HOLDINGS PLC united kingdom
SCANCELL LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Apr 2026OfficersTermination of Sathijeevan Nirmalananthan as director on 24 Apr 2026
26 Apr 2026OfficersTermination of Sathijeevan Nirmalananthan as director on 24 Apr 2026
26 Apr 2026OfficersAppointment of Alexander Hayward as director on 24 Apr 2026
9 Oct 2025AccountsAnnual accounts made up to 30 Apr 2025
28 Jul 2025Confirmation StatementConfirmation statement made on 20 Jul 2025 with no updates
26 Apr 2026 Officers

Termination of Sathijeevan Nirmalananthan as director on 24 Apr 2026

26 Apr 2026 Officers

Termination of Sathijeevan Nirmalananthan as director on 24 Apr 2026

26 Apr 2026 Officers

Appointment of Alexander Hayward as director on 24 Apr 2026

9 Oct 2025 Accounts

Annual accounts made up to 30 Apr 2025

28 Jul 2025 Confirmation Statement

Confirmation statement made on 20 Jul 2025 with no updates

Recent Activity

Latest Activity

Termination of Sathijeevan Nirmalananthan as director on 24 Apr 2026

2 weeks ago on 26 Apr 2026

Termination of Sathijeevan Nirmalananthan as director on 24 Apr 2026

2 weeks ago on 26 Apr 2026

Appointment of Alexander Hayward as director on 24 Apr 2026

2 weeks ago on 26 Apr 2026

Annual accounts made up to 30 Apr 2025

7 months ago on 9 Oct 2025

Confirmation statement made on 20 Jul 2025 with no updates

9 months ago on 28 Jul 2025